Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Arlene Weintraub


Arlene Weintraub is a Bloomberg Businessweek contributor.

Previously, she was named a senior writer for BusinessWeek‘s Science & Technology department in September 2007.

Weintraub joined BusinessWeek‘s Los Angeles bureau in 2000, covering info tech and biotech, and moved to the Sci-Tech team in New York in 2004. She has produced a string of cover stories, elegant features, and investigative pieces. Her 2006 cover story “Forever Young” won awards from the New York Press Club and Association of Health Care Journalists. She received an American Society of Business Publication Editors Gold Award in feature writing for the 2004 cover story “I Can’t Sleep.”

Prior to joining BusinessWeek, Weintraub was a senior editor at P.O.V. magazine in New York, where she wrote about a wide variety of issues, including e-commerce. Weintraub also worked at Home Office Computing, Individual Investor, and Tucson Lifestyle magazines, and she contributed stories about business and finance to a number of publications, including the New York Times.

Weintraub received her bachelor’s degree from the University of Pennsylvania and is a graduate of Medill School of Journalism at Northwestern University. In her spare time, she plays oboe and flute in chamber music groups.

Arlene Weintraub

Articles by Arlene Weintraub


  • Amgen's Uphill Marketing Battle
    Shares of the biotech giant surged on signs its bone-loss treatment is effective, but getting doctors to prescribe the drug will be tough
  • Painkiller Dosage: It's J&J vs. Wyeth
    The suggested FDA curb on acetaminophen dosage has set the two companies battling over the relative safety of rival classes of analgesics
  • Biotech: Generics Win a Round
    The White House has endorsed a seven-year limit to data exclusivity. One big winner: Teva Pharmaceuticals
  • The Fight Over Drug Data Mining
    Prescription-data collector IMS's legal drama unfolds in a battle over privacy and free speech, and could be headed to the Supreme Court